methyl isobutyl ketone has been researched along with Kidney Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borghoff, SJ; Davis, J; Green, S; Hard, GC; Hughes, B; Lynch, AM; Mensing, T; Poet, TS; Sarang, SS | 1 |
| Berdasco, NM; Borghoff, SJ; Gingell, R; Green, SM; Gulledge, W; Hard, GC | 1 |
2 other study(ies) available for methyl isobutyl ketone and Kidney Diseases
| Article | Year |
|---|---|
Methyl isobutyl ketone exposure-related increases in specific measures of α2u-globulin (α2u) nephropathy in male rats along with in vitro evidence of reversible protein binding.
Topics: Alpha-Globulins; Animals; Cell Proliferation; Dose-Response Relationship, Drug; Female; Inhalation Exposure; Kidney; Kidney Diseases; Male; Methyl n-Butyl Ketone; Organ Size; Protein Binding; Rats, Inbred F344; Risk Assessment; Sex Factors; Signal Transduction; Solvents; Time Factors | 2015 |
Methyl isobutyl ketone (MIBK) induction of alpha2u-globulin nephropathy in male, but not female rats.
Topics: Administration, Oral; Alpha-Globulins; Animals; Cell Proliferation; Female; Immunohistochemistry; Kidney Diseases; Male; Methyl n-Butyl Ketone; Organ Size; Proliferating Cell Nuclear Antigen; Rats; Rats, Inbred F344 | 2009 |